Peterse H - Search Results

1

Prognostic factors for survival after breast conserving therapy for stage I and II breast cancer. The role of local recurrence.

Kemperman H, Borger J, Hart A, Peterse H, Bartelink H, van Dongen J. Kemperman H, et al. Among authors: peterse h. Eur J Cancer. 1995;31A(5):690-8. doi: 10.1016/0959-8049(94)00526-b. Eur J Cancer. 1995. PMID: 7640040

2

Predicting a local recurrence after breast-conserving therapy by gene expression profiling.

Nuyten DS, Kreike B, Hart AA, Chi JT, Sneddon JB, Wessels LF, Peterse HJ, Bartelink H, Brown PO, Chang HY, van de Vijver MJ. Nuyten DS, et al. Among authors: peterse hj. Breast Cancer Res. 2006;8(5):R62. doi: 10.1186/bcr1614. Breast Cancer Res. 2006. PMID: 17069664 Free PMC article.

3

Continuing risk of ipsilateral breast relapse after breast-conserving therapy at long-term follow-up.

Kreike B, Hart AA, van de Velde T, Borger J, Peterse H, Rutgers E, Bartelink H, van de Vijver MJ. Kreike B, et al. Among authors: peterse h. Int J Radiat Oncol Biol Phys. 2008 Jul 15;71(4):1014-21. doi: 10.1016/j.ijrobp.2007.11.029. Epub 2008 Jan 30. Int J Radiat Oncol Biol Phys. 2008. PMID: 18234444

4

Risk factors in breast-conservation therapy.

Borger J, Kemperman H, Hart A, Peterse H, van Dongen J, Bartelink H. Borger J, et al. Among authors: peterse h. J Clin Oncol. 1994 Apr;12(4):653-60. doi: 10.1200/JCO.1994.12.4.653. J Clin Oncol. 1994. PMID: 8151313

5

Gene expression profiles of primary breast carcinomas from patients at high risk for local recurrence after breast-conserving therapy.

Kreike B, Halfwerk H, Kristel P, Glas A, Peterse H, Bartelink H, van de Vijver MJ. Kreike B, et al. Among authors: peterse h. Clin Cancer Res. 2006 Oct 1;12(19):5705-12. doi: 10.1158/1078-0432.CCR-06-0805. Clin Cancer Res. 2006. PMID: 17020974

6

Using histopathology breast cancer data to reduce clinical target volume margins at radiotherapy.

Stroom J, Schlief A, Alderliesten T, Peterse H, Bartelink H, Gilhuijs K. Stroom J, et al. Among authors: peterse h. Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):898-905. doi: 10.1016/j.ijrobp.2009.01.026. Epub 2009 May 4. Int J Radiat Oncol Biol Phys. 2009. PMID: 19409724

7

Lymphedema-induced lymphangiosarcoma.

Janse AJ, van Coevorden F, Peterse H, Keus RB, van Dongen JA. Janse AJ, et al. Among authors: peterse h. Eur J Surg Oncol. 1995 Apr;21(2):155-8. doi: 10.1016/s0748-7983(95)90270-8. Eur J Surg Oncol. 1995. PMID: 7720889

8

Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas.

Kreike B, van Kouwenhove M, Horlings H, Weigelt B, Peterse H, Bartelink H, van de Vijver MJ. Kreike B, et al. Among authors: peterse h. Breast Cancer Res. 2007;9(5):R65. doi: 10.1186/bcr1771. Breast Cancer Res. 2007. PMID: 17910759 Free PMC article.

9

Further evaluation of the prognostic value of morphometric and flow cytometric parameters in breast-cancer patients with long follow-up.

Uyterlinde AM, Baak JP, Schipper NW, Peterse H, Matze E, Meijer CJ. Uyterlinde AM, et al. Among authors: peterse h. Int J Cancer. 1990 Jan 15;45(1):1-7. doi: 10.1002/ijc.2910450102. Int J Cancer. 1990. PMID: 2298493

10

Prognostic value of morphometry and DNA flow-cytometry features of invasive breast cancers detected by population screening: comparison with control group of hospital patients.

Uyterlinde AM, Baak JP, Schipper NW, Peterse HJ, Meijer JW, Vooys PG, Matze E. Uyterlinde AM, et al. Among authors: peterse hj. Int J Cancer. 1991 May 10;48(2):173-81. doi: 10.1002/ijc.2910480204. Int J Cancer. 1991. PMID: 2019464

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters